Which of these drugs DO NOT decrease angiotensin II activity:
**Core Concept**
The renin-angiotensin-aldosterone system (RAAS) plays a crucial role in regulating blood pressure and fluid balance. Angiotensin II is a potent vasoconstrictor and aldosterone secretagogue that increases blood pressure. Inhibiting angiotensin II activity is a key mechanism for several antihypertensive drugs.
**Why the Correct Answer is Right**
Angiotensin-converting enzyme (ACE) inhibitors, such as lisinopril, and angiotensin receptor blockers (ARBs), like losartan, directly decrease angiotensin II activity. ACE inhibitors prevent the conversion of angiotensin I to angiotensin II, while ARBs block the angiotensin II type 1 receptor, thereby preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II.
**Why Each Wrong Option is Incorrect**
**Option A:** Enalapril is an ACE inhibitor, which decreases angiotensin II activity. Therefore, it is incorrect that enalapril does not decrease angiotensin II activity.
**Option B:** Losartan is an ARB, which directly blocks the angiotensin II type 1 receptor, thereby decreasing angiotensin II activity. Thus, it is incorrect that losartan does not decrease angiotensin II activity.
**Option C:** Spironolactone is a potassium-sparing diuretic that acts as an aldosterone antagonist. Although it indirectly affects the RAAS system, it does not directly decrease angiotensin II activity. However, it's worth noting that spironolactone can increase renin release, which may indirectly decrease angiotensin II activity.
**Clinical Pearl / High-Yield Fact**
Remember that ACE inhibitors and ARBs have distinct mechanisms of action, but both classes are effective in decreasing angiotensin II activity and are often used to treat hypertension and heart failure.
**Correct Answer:** C. Spironolactone.